PubMed

Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.

Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.

Br J Ophthalmol. 2008 Jul;92(7):989-91.PMID: 18577653 [PubMed - indexed for MEDLINE]Related articles

Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.

Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.

Invest Ophthalmol Vis Sci. 2008 May;49(5):1809-13. Epub 2008 Feb 8.PMID: 18263811 [PubMed - indexed for MEDLINE]Related articlesFree article

Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.

Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S.

Br J Ophthalmol. 2007 Jul;91(7):962-5. Epub 2007 Feb 21.PMID: 17314152 [PubMed - indexed for MEDLINE]Related articles

Innate immunity of the ocular surface and ocular surface inflammatory disorders.

Ueta M.

Cornea. 2008 Sep;27 Suppl 1:S31-40.PMID: 18813073 [PubMed - indexed for MEDLINE]Related articles

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.

Ueta M, Tokunaga K, Sotozono C, Inatomi T, Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S.

Mol Vis. 2008 Mar 17;14:550-5.PMID: 18385790 [PubMed - indexed for MEDLINE]Related articlesFree article

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.

Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.

Pharmacogenet Genomics. 2009 Sep;19(9):704-9.PMID: 19696695 [PubMed - indexed for MEDLINE]Related articles

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.

Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H.

Am J Pathol. 2003 May;162(5):1515-20.PMID: 12707034 [PubMed - indexed for MEDLINE]Related articlesFree article

Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.

Abe R.

J Dermatol Sci. 2008 Dec;52(3):151-9. Epub 2008 Jul 26. Review.PMID: 18657400 [PubMed - indexed for MEDLINE]Related articles

Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.

Murata J, Abe R, Shimizu H.

J Allergy Clin Immunol. 2008 Nov;122(5):992-1000. Epub 2008 Aug 9.PMID: 18692887 [PubMed - indexed for MEDLINE]Related articles

Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.

Ueta M, Sotozono C, Tokunaga K, Yabe T, Kinoshita S.

Am J Ophthalmol. 2007 Feb;143(2):367-8. Epub 2006 Oct 25.PMID: 17258541 [PubMed - indexed for MEDLINE]Related articles

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.

Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.

Br J Dermatol. 2006 Feb;154(2):319-24.PMID: 16433803 [PubMed - indexed for MEDLINE]Related articles

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R; JSAR research group.

Pharmacogenomics. 2008 Nov;9(11):1617-22.PMID: 19018717 [PubMed - indexed for MEDLINE]Related articles

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R.

Lancet. 1999 Jun 26;353(9171):2190-4.PMID: 10392983 [PubMed - indexed for MEDLINE]Related articles

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT.

Pharmacogenet Genomics. 2006 Apr;16(4):297-306.PMID: 16538176 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Khalili B, Bahna SL.

Ann Allergy Asthma Immunol. 2006 Sep;97(3):272-80; quiz 281-3, 320. Review.PMID: 17042130 [PubMed - indexed for MEDLINE]Related articles

Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O, Dix LP, Twomey JA, Stern RS.

Pharmacogenomics. 2007 Dec;8(12):1661-91.PMID: 18085998 [PubMed - indexed for MEDLINE]Related articles

Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

French LE.

Allergol Int. 2006 Mar;55(1):9-16. Review.PMID: 17075281 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

Marzano AV, Frezzolini A, Caproni M, Parodi A, Fanoni D, Quaglino P, Girgenti V, La Placa M, Fabbri P, Caputo R, Berti E.

Int J Immunopathol Pharmacol. 2007 Jul-Sep;20(3):557-66.PMID: 17880768 [PubMed - indexed for MEDLINE]Related articles

Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.

Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ.

Allergy. 2007 May;62(5):527-31. Epub 2007 Feb 20.PMID: 17313402 [PubMed - indexed for MEDLINE]Related articles

Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.

Quaglino P, Caproni M, Antiga E, Del Bianco E, Osella-Abate S, Savoia P, Frezzolini A, Schena D, Marzano A, Volpi W, De Simone C, Parodi A, Fabbri P, Bernengo MG; Italian Group of Immunopathology.

Dermatology. 2007;214(4):296-304.PMID: 17460400 [PubMed - indexed for MEDLINE]Related articles